DK1364032T3 - Anvendelse af fusionsproteiner, hvis N-terminale del er et hirudinderivat, til fremstilling af rekombinante proteiner via sekretion fra gær - Google Patents
Anvendelse af fusionsproteiner, hvis N-terminale del er et hirudinderivat, til fremstilling af rekombinante proteiner via sekretion fra gærInfo
- Publication number
- DK1364032T3 DK1364032T3 DK02719782T DK02719782T DK1364032T3 DK 1364032 T3 DK1364032 T3 DK 1364032T3 DK 02719782 T DK02719782 T DK 02719782T DK 02719782 T DK02719782 T DK 02719782T DK 1364032 T3 DK1364032 T3 DK 1364032T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- hirudin
- acid sequence
- whose
- production
- Prior art date
Links
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical class C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 title abstract 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 5
- 108020004705 Codon Proteins 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 239000004475 Arginine Substances 0.000 abstract 2
- 102000007625 Hirudins Human genes 0.000 abstract 2
- 108010007267 Hirudins Proteins 0.000 abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 2
- 229940006607 hirudin Drugs 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10108211A DE10108211A1 (de) | 2001-02-20 | 2001-02-20 | Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen |
| PCT/EP2002/001308 WO2002070722A1 (en) | 2001-02-20 | 2002-02-08 | Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1364032T3 true DK1364032T3 (da) | 2007-02-19 |
Family
ID=7674912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02719782T DK1364032T3 (da) | 2001-02-20 | 2002-02-08 | Anvendelse af fusionsproteiner, hvis N-terminale del er et hirudinderivat, til fremstilling af rekombinante proteiner via sekretion fra gær |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20030176673A1 (de) |
| EP (1) | EP1364032B1 (de) |
| JP (1) | JP4199543B2 (de) |
| KR (1) | KR100858833B1 (de) |
| CN (1) | CN1279171C (de) |
| AT (1) | ATE342367T1 (de) |
| AU (1) | AU2002250903B2 (de) |
| BR (1) | BR0207379A (de) |
| CA (1) | CA2439042C (de) |
| CY (1) | CY1106274T1 (de) |
| DE (2) | DE10108211A1 (de) |
| DK (1) | DK1364032T3 (de) |
| ES (1) | ES2272696T3 (de) |
| IL (2) | IL157416A0 (de) |
| MX (1) | MXPA03007116A (de) |
| NO (1) | NO331376B1 (de) |
| NZ (1) | NZ527642A (de) |
| PE (1) | PE20020857A1 (de) |
| PT (1) | PT1364032E (de) |
| WO (1) | WO2002070722A1 (de) |
| ZA (1) | ZA200305868B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7638618B2 (en) * | 2001-02-20 | 2009-12-29 | Sanofi-Aventis Deutschland Gmbh | Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
| DE102006031955A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
| DE102006031962A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
| DE102008025007A1 (de) | 2008-05-24 | 2009-11-26 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| AU2009203809B2 (en) | 2008-01-09 | 2013-07-25 | Sanofi-Aventis Deutschland Gmbh | Novel insulin derivatives having an extremely delayed time-action profile |
| BRPI0907119A2 (pt) | 2008-01-09 | 2015-07-14 | Sanofi Aventis Deutschland | Derivados de insulina tendo um perfil de ação de tempo extremamente retardado |
| DE102008003566A1 (de) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
| KR101853606B1 (ko) | 2009-07-06 | 2018-05-03 | 사노피-아벤티스 도이칠란트 게엠베하 | 메티오닌을 함유하는 수성 인슐린 제제 |
| DK2498802T3 (en) | 2009-11-13 | 2015-04-13 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine |
| KR101337322B1 (ko) | 2009-11-13 | 2013-12-06 | 사노피-아벤티스 도이칠란트 게엠베하 | Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물 |
| ES2606554T3 (es) | 2010-08-30 | 2017-03-24 | Sanofi-Aventis Deutschland Gmbh | Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| PL2750699T3 (pl) | 2011-08-29 | 2015-12-31 | Sanofi Aventis Deutschland | Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2 |
| AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
| AU2015359376B2 (en) | 2014-12-12 | 2021-09-09 | Sanofi-Aventis Deutschland Gmbh | Insulin glargine/lixisenatide fixed ratio formulation |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985004418A1 (fr) * | 1984-03-27 | 1985-10-10 | Transgene S.A. | Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine |
| US5705355A (en) * | 1984-03-27 | 1998-01-06 | Transgene, S.A. | Hirudin, pharmaceutical compositions comprising it and their use |
| DE3738541A1 (de) * | 1987-11-13 | 1989-05-24 | Hoechst Ag | Verfahren zur isolierung und reinigung von hirudin |
| US6875589B1 (en) * | 1988-06-23 | 2005-04-05 | Hoechst Aktiengesellschaft | Mini-proinsulin, its preparation and use |
| GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
| DE4009268A1 (de) * | 1990-03-22 | 1991-09-26 | Consortium Elektrochem Ind | Sekretion von hirudinderivaten |
| ES2129749T3 (es) * | 1990-11-08 | 1999-06-16 | Japan Energy Corp | Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo. |
| FI92601C (fi) * | 1992-03-11 | 1994-12-12 | Marja Makarow | Menetelmä hyötyproteiinien erittämiseksi hiivoista |
| DE19543737A1 (de) * | 1995-11-24 | 1997-05-28 | Hoechst Ag | Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices |
| DE19544233A1 (de) * | 1995-11-28 | 1997-06-05 | Hoechst Ag | Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten |
| WO1997033973A1 (en) * | 1996-03-13 | 1997-09-18 | Delta Biotechnology Limited | Fermentation control |
| DE10033195A1 (de) * | 2000-07-07 | 2002-03-21 | Aventis Pharma Gmbh | Bifunktionale Fusionsproteine aus Hirudin und TAP |
| US7202059B2 (en) * | 2001-02-20 | 2007-04-10 | Sanofi-Aventis Deutschland Gmbh | Fusion proteins capable of being secreted into a fermentation medium |
-
2001
- 2001-02-20 DE DE10108211A patent/DE10108211A1/de not_active Withdrawn
-
2002
- 2002-02-06 PE PE2002000082A patent/PE20020857A1/es not_active Application Discontinuation
- 2002-02-08 ES ES02719782T patent/ES2272696T3/es not_active Expired - Lifetime
- 2002-02-08 AT AT02719782T patent/ATE342367T1/de active
- 2002-02-08 JP JP2002570745A patent/JP4199543B2/ja not_active Expired - Fee Related
- 2002-02-08 PT PT02719782T patent/PT1364032E/pt unknown
- 2002-02-08 AU AU2002250903A patent/AU2002250903B2/en not_active Ceased
- 2002-02-08 CN CNB028068491A patent/CN1279171C/zh not_active Expired - Fee Related
- 2002-02-08 NZ NZ527642A patent/NZ527642A/en not_active IP Right Cessation
- 2002-02-08 BR BR0207379-0A patent/BR0207379A/pt not_active Application Discontinuation
- 2002-02-08 WO PCT/EP2002/001308 patent/WO2002070722A1/en not_active Ceased
- 2002-02-08 KR KR1020037010932A patent/KR100858833B1/ko not_active Expired - Fee Related
- 2002-02-08 DK DK02719782T patent/DK1364032T3/da active
- 2002-02-08 CA CA2439042A patent/CA2439042C/en not_active Expired - Fee Related
- 2002-02-08 IL IL15741602A patent/IL157416A0/xx unknown
- 2002-02-08 DE DE60215315T patent/DE60215315T2/de not_active Expired - Lifetime
- 2002-02-08 MX MXPA03007116A patent/MXPA03007116A/es active IP Right Grant
- 2002-02-08 EP EP02719782A patent/EP1364032B1/de not_active Expired - Lifetime
- 2002-02-19 US US10/076,632 patent/US20030176673A1/en not_active Abandoned
-
2003
- 2003-07-30 ZA ZA2003/05868A patent/ZA200305868B/en unknown
- 2003-08-14 IL IL157416A patent/IL157416A/en not_active IP Right Cessation
- 2003-08-19 NO NO20033672A patent/NO331376B1/no not_active IP Right Cessation
-
2006
- 2006-11-30 CY CY20061101726T patent/CY1106274T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1364032A1 (de) | 2003-11-26 |
| ES2272696T3 (es) | 2007-05-01 |
| DE10108211A1 (de) | 2002-08-22 |
| CN1279171C (zh) | 2006-10-11 |
| WO2002070722A1 (en) | 2002-09-12 |
| IL157416A (en) | 2009-08-03 |
| NO20033672L (no) | 2003-10-17 |
| NO20033672D0 (no) | 2003-08-19 |
| ZA200305868B (en) | 2005-02-23 |
| US20030176673A1 (en) | 2003-09-18 |
| PE20020857A1 (es) | 2002-11-04 |
| NZ527642A (en) | 2005-03-24 |
| CY1106274T1 (el) | 2011-10-12 |
| ATE342367T1 (de) | 2006-11-15 |
| HK1065068A1 (en) | 2005-02-08 |
| DE60215315D1 (de) | 2006-11-23 |
| KR20030074841A (ko) | 2003-09-19 |
| PT1364032E (pt) | 2007-01-31 |
| DE60215315T2 (de) | 2007-05-24 |
| KR100858833B1 (ko) | 2008-09-17 |
| AU2002250903B2 (en) | 2006-12-07 |
| IL157416A0 (en) | 2004-03-28 |
| BR0207379A (pt) | 2004-06-15 |
| EP1364032B1 (de) | 2006-10-11 |
| CA2439042C (en) | 2013-06-18 |
| MXPA03007116A (es) | 2003-11-18 |
| NO331376B1 (no) | 2011-12-12 |
| CA2439042A1 (en) | 2002-09-12 |
| JP4199543B2 (ja) | 2008-12-17 |
| CN1526021A (zh) | 2004-09-01 |
| JP2004518446A (ja) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033672D0 (no) | Anvendelse av fusjonsproteiner der den N-terminale delen er et hirudinderivat for fremstilling av rekombinante proteiner via sekresjon fragj¶r | |
| Vedvick et al. | High-level secretion of biologically active aprotinin from the yeast Pichia pastoris | |
| Lind et al. | Novel forms of B‐domain‐deleted recombinant factor VIII molecules: construction and biochemical characterization | |
| AU2002231784B2 (en) | Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture | |
| CN103328649B (zh) | 用于改善重组酶及其它蛋白的蛋白表达和分泌的新的信号序列 | |
| EP0399666A1 (de) | N-terminale Fragmente von menschliches Serumalbumin enthaltenden Fusionsproteinen | |
| JP2553058B2 (ja) | 真核性のバラスト部分を有する融合タンパク質 | |
| TW200732472A (en) | Method for the recombinant expression of a polypeptide | |
| JP2008502313A (ja) | 単鎖インシュリン | |
| IL157415A0 (en) | Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides | |
| JP2574048B2 (ja) | エラスターゼ阻害活性ポリペプチド及び遺伝子組換えによるその製造方法 | |
| Bourbonnais et al. | Production of full-length human pre-elafin, an elastase specific inhibitor, from yeast requires the absence of a functional yapsin 1 (Yps1p) endoprotease | |
| WO2019237079A2 (en) | Pharmaceutical composition containing fusion protein and use thereof | |
| JPH05500615A (ja) | ヒルジン及び新規のヒルジンの組換え製造方法 | |
| US7344856B1 (en) | Method of controlling cleavage by OmpT protease | |
| JP5757639B2 (ja) | セルピンフィンガー融合ポリペプチド | |
| Yang et al. | Expression and localization of recombinant human EDG-1 receptors in Pichia pastoris | |
| WO1995035376A2 (en) | Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains | |
| Shen et al. | A Novel Approach for Secretion of Heterologous Proteins with Correct N-Terminal Processing by Using α-Factor Pre Sequence in Pichia pastoris | |
| Rao et al. | Transgenic expression in tobacco of a poly-proctolin construct leading to production of the bioactive peptide | |
| AU2816099A (en) | Insulin binding polypeptide | |
| Human | Construction of pPIC9 Recombinant Vector Containing Human Stem Cell Factor |